Department of Health and Social Care written question – answered at on 27 November 2018.
Ranil Jayawardena
Conservative, North East Hampshire
To ask the Secretary of State for Health and Social Care, what progress he has made on the acquisition of Orkambi for the NHS.
Steve Brine
The Parliamentary Under-Secretary for Health and Social Care
The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.
Yes3 people think so
No1 person thinks not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
